Accessibility Menu
Sensus Healthcare Stock Quote

Sensus Healthcare (NASDAQ: SRTS)

$4.26
(-2.1%)
-0.09
Price as of March 10, 2026, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$4.26
Daily Change
(-2.1%) $0.09
Day's Range
$4.26 - $4.38
Previous Close
$4.26
Open
$4.38
Beta
0.90
Volume
645
Average Volume
100,248
Market Cap
$70M
Market Cap / Employee
$4.25M
52wk Range
$3.03 - $5.92
Revenue
N/A
Gross Margin
0.43%
Dividend Yield
N/A
EPS
-$0.47
CAPs Rating
N/A
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Sensus Healthcare Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
SRTS-2.3%+2.16%+0.43%-26%
S&P+20.78%+72.15%+11.48%+213%

Sensus Healthcare Company Info

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

News & Analysis

Financial Health

General

Q4 2025YOY Change
Revenue$4.94M-62.2%
Gross Profit$1.90M-73.3%
Gross Margin38.43%-16.0%
Market Cap$65.37M-42.4%
Market Cap / Employee$1.09M0.0%
Employees6011.1%
Net Income-$3,167.00K-304.9%
EBITDA-$2,985.00K-260.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q4 2025YOY Change
Net Cash$22.08M0.1%
Accounts Receivable$6.04M-69.4%
Inventory16.119.6%

Liabilities

Q4 2025YOY Change
Long Term Debt$209.00K-47.5%
Short Term Debt$262.00K28.4%

Ratios

Q4 2025YOY Change
Return On Assets-13.40%-24.9%
Return On Invested Capital9.59%3.5%

Cash Flow

Q4 2025YOY Change
Free Cash Flow-$2,365.00K-346.2%
Operating Free Cash Flow-$2,207.00K-166.9%

Valuation

MetricQ2 2024Q3 2024Q4 2024Q1 2025YoY Change
Price to Earnings13.0710.1517.0243.04223.36%
Price to Book1.401.470.991.28-39.00%
Price to Sales1.962.061.442.36-13.11%
Price to Tangible Book Value1.401.470.991.28-39.00%
Price to Free Cash Flow TTM16.7022.1523.65195.72331.67%
Enterprise Value to EBITDA-23.54-31.25-11.34-14.53-129.27%
Free Cash Flow Yield6.0%4.5%4.2%0.5%-76.83%
Return on Equity3.5%-1.6%-5.7%-14.9%-216.96%
Total Debt$654.00K$595.00K$534.00K$471.00K-21.76%

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.